Oryzon Genomics SA (ORYZF)

3.31 0.00 (0.00%) USD  |  OTCM  |  Sep 28, 16:00
More

Oryzon Genomics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ORYZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2016 --

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Pharma Mar SA Upgrade
Grifols SA Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alkermes Plc Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade